Prebiotics

Any nondigestible food component that stimulates the growth and/or activity of bacteria in ways claimed to be beneficial to health.

Lux logo LUX TAKE:

Ingredients that enhance the health of the human gut microflora, namely prebiotics and probiotics, will become further integrated into diversified food and beverage formats. As this occurs, ingredient manufacturers and CPGs should look to capitalize on three major trends occurring within the prebiotics space: 1) Effectiveness at lower doses is a key differentiator, 2) prebiotics with inherent ...


Lux Take last updated on July 14, 2020
Data last updated on October 21, 2021

What's New

Lux Research analysts and the Lux Intelligence Engine have added the following recent prebiotics developments.

News Commentaries

New rare sugar on the block: EnginZyme pilots cell-free production of kojibiose (October 19, 2021)

EU and U.S. to launch Global Methane Pledge at COP26 (September 24, 2021)

New Lux Content

Microbiome-based Business Opportunities for Consumer Products (September 30, 2021)

Atmo Biosciences (August 19, 2021)

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978

© 2004-2021 Lux Research, Inc. All Lux Research content is intended only for consumption by Lux Research clients; redistribution is prohibited and copyright is strictly enforced. All material is based on information obtained from sources believed to be reliable but no independent verification has been made, nor is its accuracy or completeness guaranteed. All material is published solely for informational purposes and is not to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments.